Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizontal transfer of neoplastic traits, and the emergence of therapeutic resistance

Siegel, 2020, Cancer statistics, CA Cancer J. Clin., 70, 7, 10.3322/caac.21590 Maman, 2018, A history of exploring cancer in context, Nat. Rev. Cancer, 18, 359, 10.1038/s41568-018-0006-7 van Niel, 2018, Shedding light on the cell biology of extracellular vesicles, Nat. Rev. Mol. Cell Biol., 19, 213, 10.1038/nrm.2017.125 Wolf, 1967, The nature and significance of platelet products in human plasma, Br. J. Haematol., 13, 269, 10.1111/j.1365-2141.1967.tb08741.x Harding, 1983, Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes, J. Cell Biol., 97, 329, 10.1083/jcb.97.2.329 Pan, 1983, Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor, Cell, 33, 967, 10.1016/0092-8674(83)90040-5 Nagarajah, 2016, Exosome secretion — more than simple waste disposal? Implications for physiology, diagnostics and therapeutics, J. Circ. Biomark., 5, 10.33393/jcb.2016.2075 Raposo, 1996, B lymphocytes secrete antigen-presenting vesicles, J. Exp. Med., 183, 1161, 10.1084/jem.183.3.1161 Shah, 2018, Circulating extracellular vesicles in human disease, N. Engl. J. Med., 379, 2180 Yuan, 2016, Spatial heterogeneity in the tumor microenvironment, Cold Spring Harb. Perspect. Med., 6, 10.1101/cshperspect.a026583 da Cunha, 2019, Cellular interactions in the tumor microenvironment: the role of secretome, J. Cancer, 10, 4574, 10.7150/jca.21780 Haralambiev, 2018, Effects of cold atmospheric plasma on the expression of chemokines, growth factors, TNF superfamily members, interleukins, and cytokines in human osteosarcoma cells, Anticancer Res., 39, 151, 10.21873/anticanres.13091 Henke, 2020, Extracellular matrix in the tumor microenvironment and its impact on Cancer therapy, Front. Mol. Biosci., 6, 10.3389/fmolb.2019.00160 Al-Nedawi, 2008, Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nat. Cell Biol., 10, 619, 10.1038/ncb1725 Al-Nedawi, 2009, Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR, Proc. Natl. Acad. Sci. U.S.A., 106, 3794, 10.1073/pnas.0804543106 Théry, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1535750 Zhang, 2019, The biology and therapeutic applications of red blood cell extracellular vesicles, Erythrocyte, 10.5772/intechopen.81758 Merchant, 2017, Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery, Nat. Rev. Nephrol., 13, 731, 10.1038/nrneph.2017.148 Iwai, 2016, Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations, J. Extracell. Vesicles, 5, 10.3402/jev.v5.30829 Xu, 2018, Extracellular vesicles in cancer — implications for future improvements in cancer care, Nat. Rev. Clin. Oncol., 15, 617, 10.1038/s41571-018-0036-9 Palviainen, 2019, Metabolic signature of extracellular vesicles depends on the cell culture conditions, J. Extracell. Vesicles, 8, 10.1080/20013078.2019.1596669 Verderio, 2018, Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles, J. Lipid Res., 59, 1325, 10.1194/jlr.R083915 Haraszti, 2016, High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources, J. Extracell. Vesicles, 5, 10.3402/jev.v5.32570 Pfrieger, 2018, Cholesterol and the journey of extracellular vesicles, J. Lipid Res., 59, 2255, 10.1194/jlr.R084210 Catalano, 2019, Inhibiting extracellular vesicles formation and release: a review of EV inhibitors, J. Extracell. Vesicles, 9, 10.1080/20013078.2019.1703244 Cone, 2020, Alix and Syntenin-1 direct amyloid precursor protein trafficking into extracellular vesicles, BMC Mol. Cell Biol., 21, 10.1186/s12860-020-00302-0 Andreu, 2014, Tetraspanins in extracellular vesicle formation and function, Front. Immunol., 5, 10.3389/fimmu.2014.00442 Sung, 2020, A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells, Nat. Commun., 11, 10.1038/s41467-020-15747-2 Scavo, 2019, Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric Cancer, J. Oncol., 2019, 1, 10.1155/2019/2715968 Hoshino, 2015, Tumour exosome integrins determine organotropic metastasis, Nature, 527, 329, 10.1038/nature15756 Momen-Heravi, 2018, Extracellular vesicles and their nucleic acids for biomarker discovery, Pharmacol. Ther., 192, 170, 10.1016/j.pharmthera.2018.08.002 O’Brien, 2020, RNA delivery by extracellular vesicles in mammalian cells and its applications, Nat. Rev. Mol. Cell Biol., 10.1038/s41580-020-0251-y Pirisinu, 2020, Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: recent advances, current obstacles, and challenges for clinical translation, Semin. Cancer Biol. Dang, 2020, Extracellular vesicles as an efficient and versatile system for drug delivery, Cells, 9, 10.3390/cells9102191 Zebrowska, 2019, Metabolome of exosomes: focus on vesicles released by Cancer cells and present in human body fluids, Int. J. Mol. Sci., 20, 10.3390/ijms20143461 Zhao, 2016, Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism, eLife, 5, 10.7554/eLife.10250 Clos-Garcia, 2018, Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1470442 Kowal, 2016, Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes, Proc. Natl. Acad. Sci. U.S.A., 113, E968, 10.1073/pnas.1521230113 Ramirez, 2018, Technical challenges of working with extracellular vesicles, Nanoscale, 10, 881, 10.1039/C7NR08360B Maas, 2017, Tunable resistive pulse sensing for the characterization of extracellular vesicles, Exosomes Microves., 21, 10.1007/978-1-4939-6728-5_2 Görgens, 2019, Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material, J. Extracell. Vesicles, 8, 10.1080/20013078.2019.1587567 Meldolesi, 2018, Exosomes and ectosomes in intercellular communication, Curr. Biol., 28, R435, 10.1016/j.cub.2018.01.059 Kaur, 2018, Early endosome morphology in health and disease, Retinal Degenerat. Diseases, 335, 10.1007/978-3-319-75402-4_41 Nagano, 2019, Rab5-mediated endosome formation is regulated at the trans-Golgi network, Commun. Biol., 2, 10.1038/s42003-019-0670-5 Jongsma, 2016, An ER-Associated pathway defines endosomal architecture for controlled cargo transport, Cell, 166, 152, 10.1016/j.cell.2016.05.078 Langemeyer, 2018, Rab GTPase function in Endosome and lysosome biogenesis, Trends Cell Biol., 28, 957, 10.1016/j.tcb.2018.06.007 Vietri, 2019, The many functions of ESCRTs, Nat. Rev. Mol. Cell Biol., 21, 25, 10.1038/s41580-019-0177-4 Karim, 2018, Distinct features of multivesicular body-lysosome fusion revealed by a new cell-free content-mixing assay, Traffic, 19, 138, 10.1111/tra.12543 Bebelman, 2019, Real-time imaging of multivesicular body–plasma membrane fusion to quantify exosome release from single cells, Nat. Protoc., 15, 102, 10.1038/s41596-019-0245-4 Cocucci, 2011, Ectosomes, Curr. Biol., 21, R940, 10.1016/j.cub.2011.10.011 Tricarico, 2016, Biology and biogenesis of shed microvesicles, Small GTPases, 8, 220, 10.1080/21541248.2016.1215283 Lingwood, 2009, Lipid rafts As a membrane-organizing principle, Science, 327, 46, 10.1126/science.1174621 Holowka, 2017, Psychosine enhances the shedding of membrane microvesicles: implications in demyelination in Krabbe’s disease, PLoS One, 12 Muralidharan-Chari, 2010, Microvesicles: mediators of extracellular communication during cancer progression, J. Cell. Sci., 123, 1603, 10.1242/jcs.064386 Segawa, 2018, Phospholipid flippases enable precursor B cells to flee engulfment by macrophages, Proc. Natl. Acad. Sci. U.S.A., 115, 12212, 10.1073/pnas.1814323115 Hankins, 2015, Role of Flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution, Traffic, 16, 35, 10.1111/tra.12233 Beer, 2018, Extracellular vesicle budding is inhibited by redundant regulators of TAT-5 flippase localization and phospholipid asymmetry, Proc. Natl. Acad. Sci. U.S.A., 115, E1127, 10.1073/pnas.1714085115 Nabhan, 2012, Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein, Proc. Natl. Acad. Sci. U.S.A., 109, 4146, 10.1073/pnas.1200448109 Crawford, 2010, Effect of increased extracellular Ca++ on microvesicle production and tumor spheroid formation, Cancer Microenviron., 4, 93, 10.1007/s12307-010-0049-0 Li, 2012, RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells, Oncogene, 31, 4740, 10.1038/onc.2011.636 Dai, 2019, RhoA inhibitor suppresses the production of microvesicles and rescues high ventilation induced lung injury, Int. Immunopharmacol., 72, 74, 10.1016/j.intimp.2019.03.059 Xu, 2019, Apoptosis and apoptotic body: disease message and therapeutic target potentials, Biosci. Rep., 39, 10.1042/BSR20180992 Battistelli, 2020, Particular extracellular vesicles involved in intercellular communication, Biology, 9, 10.3390/biology9010021 Willms, 2018, Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in Cancer progression, Front. Immunol., 9, 10.3389/fimmu.2018.00738 Mathieu, 2019, Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication, Nat. Cell Biol., 21, 9, 10.1038/s41556-018-0250-9 Horibe, 2018, Mechanism of recipient cell-dependent differences in exosome uptake, BMC Cancer, 18, 10.1186/s12885-017-3958-1 Chivet, 2014, Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons, J. Extracell. Vesicles, 3, 10.3402/jev.v3.24722 Gonda, 2019, Internalization of exosomes through receptor-mediated endocytosis, Mol. Cancer Res., 17, 337, 10.1158/1541-7786.MCR-18-0891 Nakase, 2015, Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes, Sci. Rep., 5, 10.1038/srep10300 Kaur, 2014, CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells, Matrix Biol., 37, 49, 10.1016/j.matbio.2014.05.007 Kaur, 2017, A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells, J. Cell Commun. Signal., 12, 157, 10.1007/s12079-017-0428-0 Kamerkar, 2017, Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer, Nature, 546, 498, 10.1038/nature22341 Fuentes, 2020, ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells, Nat. Commun., 11 Gonda, 2018, Exosomal survivin facilitates vesicle internalization, Oncotarget, 9, 34919, 10.18632/oncotarget.26182 Christianson, 2013, Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity, Proc. Natl. Acad. Sci. U.S.A., 110, 17380, 10.1073/pnas.1304266110 Kim, 2019, Citraconylated exosomes for improved internalization into macrophages, Appl. Biol. Chem., 62, 10.1186/s13765-019-0433-5 Joshi, 2020, Endocytosis of extracellular vesicles and release of their cargo from endosomes, ACS Nano, 14, 4444, 10.1021/acsnano.9b10033 Parolini, 2009, Microenvironmental pH is a key factor for exosome traffic in tumor cells, J. Biol. Chem., 284, 34211, 10.1074/jbc.M109.041152 Heath, 2019, Endosomal escape enhancing compounds facilitate functional delivery of extracellular vesicle cargo, Nanomedicine, 14, 2799, 10.2217/nnm-2019-0061 Vu, 2020, microRNA exchange via extracellular vesicles in cancer, Cell Prolif., 53, 10.1111/cpr.12877 Tkach, 2017, Qualitative differences in T‐cell activation by dendritic cell‐derived extracellular vesicle subtypes, EMBO J., 36, 3012, 10.15252/embj.201696003 Zanconato, 2019, YAP and TAZ: a signalling hub of the tumour microenvironment, Nat. Rev. Cancer, 19, 454, 10.1038/s41568-019-0168-y Burgos-Panadero, 2019, The tumour microenvironment as an integrated framework to understand cancer biology, Cancer Lett., 461, 112, 10.1016/j.canlet.2019.07.010 Quail, 2017, The microenvironmental landscape of brain tumors, Cancer Cell, 31, 326, 10.1016/j.ccell.2017.02.009 Yan, 2019, Cancer‐associated fibroblasts–derived exosomes‐mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion, Cell Biochem. Funct., 38, 257, 10.1002/cbf.3462 Zhang, 2015, Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth, Nature, 527, 100, 10.1038/nature15376 Aasen, 2016, Gap junctions and cancer: communicating for 50 years, Nat. Rev. Cancer, 16, 775, 10.1038/nrc.2016.105 Mendoza-Naranjo, 2007, Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells, J. Immunol., 178, 6949, 10.4049/jimmunol.178.11.6949 Venkataramani, 2019, Glutamatergic synaptic input to glioma cells drives brain tumour progression, Nature, 573, 532, 10.1038/s41586-019-1564-x Venkatesh, 2019, Electrical and synaptic integration of glioma into neural circuits, Nature, 573, 539, 10.1038/s41586-019-1563-y Zeng, 2019, Synaptic proximity enables NMDAR signalling to promote brain metastasis, Nature, 573, 526, 10.1038/s41586-019-1576-6 Robinson, 2002, Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α, Eur. J. Immunol., 32, 404, 10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-X Sukkurwala, 2013, Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8, Cell Death Differ., 21, 59, 10.1038/cdd.2013.73 Tessema, 2010, Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis, Oncogene, 29, 5159, 10.1038/onc.2010.255 Gerarduzzi, 2020, The matrix revolution: matricellular proteins and restructuring of the Cancer microenvironment, Cancer Res., 80, 2705, 10.1158/0008-5472.CAN-18-2098 Ravikanth, 2011, Heterogenecity of fibroblasts, J. Oral Maxillofac. Pathol., 15, 10.4103/0973-029X.84516 Desmouliere, 2014, Fibroblasts and myofibroblasts in wound healing, Clinical, Cosmetic and Investigational Dermatology, 10.2147/CCID.S50046 Liu, 2019, Cancer-associated fibroblasts build and secure the tumor microenvironment, Front. Cell Dev. Biol., 7, 10.3389/fcell.2019.00060 Ji, 2020, Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation, Nat. Commun., 11, 10.1038/s41467-020-14869-x Liu, 2017, NF-κB signaling in inflammation, Signal Transduct. Target. Ther., 2, 10.1038/sigtrans.2017.23 Vu, 2019, Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b, J. Extracell. Vesicles, 8, 10.1080/20013078.2019.1599680 Umakoshi, 2018, Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor microenvironment, Oncogene, 38, 2162, 10.1038/s41388-018-0564-x Kim, 2014, RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation, Proc. Natl. Acad. Sci. U.S.A., 111, 16389, 10.1073/pnas.1407097111 Lee, 2011, Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells, Int. J. Oncol., 10.3892/ijo.2011.1193 Cho, 2011, Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts, Gynecol. Oncol., 123, 379, 10.1016/j.ygyno.2011.08.005 Samant, 2012, Gastric Cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-β/Smad Pathway, PLoS One, 7 Santi, 2015, Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth, Biochimica et Biophysica Acta (BBA) – Mol. Cell Res., 1853, 3211, 10.1016/j.bbamcr.2015.09.013 Dourado, 2019, Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma, J. Extracell. Vesicles, 8, 10.1080/20013078.2019.1578525 Li, 2018, Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p, EBioMedicine, 36, 209, 10.1016/j.ebiom.2018.09.006 Gonzalez, 2018, Roles of the immune system in cancer: from tumor initiation to metastatic progression, Genes Dev., 32, 1267, 10.1101/gad.314617.118 Klose, 2016, Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis, Nat. Immunol., 17, 765, 10.1038/ni.3489 Schmiedel, 2018, NKG2D ligands–Critical targets for Cancer Immune escape and therapy, Front. Immunol., 9, 10.3389/fimmu.2018.02040 Busson, 2014, Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ t cells: mechanism of immune evasion, PLoS One, 9 Zhao, 2019, Tumor-derived extracellular vesicles inhibit natural killer cell function in pancreatic Cancer, Cancers, 11, 10.3390/cancers11060874 Federici, 2020, Natural-killer-Derived extracellular vesicles: immune sensors and interactors, Front. Immunol., 11, 10.3389/fimmu.2020.00262 Xu, 2016, Macrophages transfer antigens to dendritic cells by releasing exosomes containing dead-cell-associated antigens partially through a ceramide-dependent pathway to enhance CD4+T-cell responses, Immunology, 149, 157, 10.1111/imm.12630 Yu, 2007, Tumor exosomes inhibit differentiation of bone marrow dendritic cells, J. Immunol., 178, 6867, 10.4049/jimmunol.178.11.6867 Valenti, 2006, Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth Factor-β–Mediated suppressive activity on t lymphocytes, Cancer Res., 66, 9290, 10.1158/0008-5472.CAN-06-1819 Chalmin, 2010, Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells, J. Clin. Invest., 10.1172/JCI40483 Xie, 2010, Dendritic cells recruit t cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of Peptide/MHC class I and fas ligand-mediated cytotoxicity, J. Immunol., 185, 5268, 10.4049/jimmunol.1000386 Liu, 2016, Donor dendritic cell–derived exosomes promote allograft-targeting immune response, J. Clin. Invest., 126, 2805, 10.1172/JCI84577 Matsumoto, 2020, Antitumor immunity by small extracellular vesicles collected from activated dendritic cells through effective induction of cellular and humoral immune responses, Biomaterials, 252, 10.1016/j.biomaterials.2020.120112 Viaud, 2010, Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What’s Next?, Cancer Res., 70, 1281, 10.1158/0008-5472.CAN-09-3276 Lin, 2019, Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications, J. Hematol. Oncol., 12, 10.1186/s13045-019-0760-3 Chen, 2018, Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype, Cancer Lett., 435, 80, 10.1016/j.canlet.2018.08.001 Cooks, 2018, Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246, Nat. Commun., 9, 10.1038/s41467-018-03224-w Gao, 2018, Tumor-derived exosomes antagonize innate antiviral immunity, Nat. Immunol., 19, 233, 10.1038/s41590-017-0043-5 Popēna, 2018, Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages, Cell Commun. Signal., 16, 10.1186/s12964-018-0229-y Antonios, 2013, Macrophage polarization in response to wear particles in vitro, Cell. Mol. Immunol., 10, 471, 10.1038/cmi.2013.39 Cheng, 2019, Macrophage polarization in the development and progression of ovarian cancers: an overview, Front. Oncol., 9, 10.3389/fonc.2019.00421 Hsu, 2018, Hypoxic lung-cancer-Derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN, Mol. Ther., 26, 568, 10.1016/j.ymthe.2017.11.016 Shinohara, 2017, Regulated polarization of tumor-associated macrophages by miR-145 via colorectal Cancer–Derived Extracellular vesicles, J. Immunol., 199, 1505, 10.4049/jimmunol.1700167 Ono, 2020, Triple knockdown of CDC37, HSP90-alpha and HSP90-beta diminishes extracellular vesicles-driven malignancy events and macrophage M2 polarization in oral cancer, J. Extracell. Vesicles, 9, 10.1080/20013078.2020.1769373 Veillette, 2018, SIRPα–CD47 immune checkpoint blockade in anticancer therapy, Trends Immunol., 39, 173, 10.1016/j.it.2017.12.005 Cianciaruso, 2019, Molecular profiling and functional analysis of macrophage-derived tumor extracellular vesicles, Cell Rep., 27, 10.1016/j.celrep.2019.05.008 Chen, 2019, Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells, Nat. Cell Biol., 21, 498, 10.1038/s41556-019-0299-0 Cheng, 2017, Exosomes from M1-Polarized macrophages potentiate the Cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node, Mol. Ther., 25, 1665, 10.1016/j.ymthe.2017.02.007 Martinez-Lostao, 2015, How Do Cytotoxic Lymphocytes Kill Cancer Cells?, Clin. Cancer Res., 21, 5047, 10.1158/1078-0432.CCR-15-0685 Prajapati, 2018, Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy, Cell. Mol. Immunol., 15, 470, 10.1038/cmi.2017.161 Wieckowski, 2009, Tumor-derived microvesicles promote regulatory t cell expansion and induce apoptosis in Tumor-Reactive activated CD8+ t lymphocytes, J. Immunol., 183, 3720, 10.4049/jimmunol.0900970 Maybruck, 2017, Tumor-derived exosomes induce CD8+ T cell suppressors, J. Immunother. Cancer, 5, 10.1186/s40425-017-0269-7 Seo, 2018, Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells, Nat. Commun., 9, 10.1038/s41467-018-02865-1 Knutson, 2005, Tumor antigen-specific T helper cells in cancer immunity and immunotherapy, Cancer immunology, Immunotherapy, 54, 721 Liu, 2018, Increased T-helper 17 cell differentiation mediated by exosome-mediated microRNA-451 redistribution in gastric cancer infiltrated T cells, Cancer Sci., 109, 65, 10.1111/cas.13429 Li, 2020, Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects, Mol. Cancer, 19, 10.1186/s12943-020-01234-1 Aiello, 2017, Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival, Sci. Rep., 7, 10.1038/s41598-017-08617-3 Ni, 2020, Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells, Signal Transduct. Target. Ther., 5, 10.1038/s41392-020-0129-7 Mrizak, 2015, Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory t cells, JNCI, 107, 10.1093/jnci/dju363 Zhou, 2018, Exosomes released from tumor-associated macrophages transfer miRNAs that induce a Treg/Th17 cell imbalance in epithelial ovarian Cancer, Cancer Immunol. Res., 6, 1578, 10.1158/2326-6066.CIR-17-0479 Muller, 2017, Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms, OncoImmunology, 6, 10.1080/2162402X.2016.1261243 Juneja, 2017, PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity, J. Exp. Med., 214, 895, 10.1084/jem.20160801 Singh, 2020, Immune checkpoint inhibitors: a promising anticancer therapy, Drug Discov. Today, 25, 223, 10.1016/j.drudis.2019.11.003 Sharonov, 2020, B cells, plasma cells and antibody repertoires in the tumour microenvironment, Nat. Rev. Immunol., 20, 294, 10.1038/s41577-019-0257-x Singel, 2016, Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal, Immunol. Rev., 273, 329, 10.1111/imr.12459 Näslund, 2013, Dendritic cell–Derived exosomes need to activate both t and B cells to induce antitumor immunity, J. Immunol., 190, 2712, 10.4049/jimmunol.1203082 Saunderson, 2017, Role of lymphocyte subsets in the immune response to primary B cell–Derived exosomes, J. Immunol., 199, 2225, 10.4049/jimmunol.1601537 Muntasell, 2007, T cell-induced secretion of MHC class II–peptide complexes on B cell exosomes, EMBO J., 26, 4263, 10.1038/sj.emboj.7601842 Zhang, 2018, Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration, Mol. Cancer, 17, 10.1186/s12943-018-0898-6 Liu, 2016, Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils, Cancer Cell, 30, 243, 10.1016/j.ccell.2016.06.021 Hwang, 2019, Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer, J. Hematol. Oncol., 12, 10.1186/s13045-019-0699-4 Park, 2016, Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps, Sci. Transl. Med., 8, 10.1126/scitranslmed.aag1711 Leal, 2017, Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis, Sci. Rep., 7, 10.1038/s41598-017-06893-7 Garcia-Bermudez, 2020, Targeting extracellular nutrient dependencies of cancer cells, Mol. Metab., 33, 67, 10.1016/j.molmet.2019.11.011 De Palma, 2017, Microenvironmental regulation of tumour angiogenesis, Nat. Rev. Cancer, 17, 457, 10.1038/nrc.2017.51 Goel, 2013, VEGF targets the tumour cell, Nat. Rev. Cancer, 13, 871, 10.1038/nrc3627 Korc, 2009, The role of fibroblast growth factors in tumor growth, Curr. Cancer Drug Targets, 9, 639, 10.2174/156800909789057006 Xue, 2011, PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells, Nat. Med., 18, 100, 10.1038/nm.2575 Finn, 2020, Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma, N. Engl. J. Med., 382, 1894, 10.1056/NEJMoa1915745 Zhang, 2020, Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma, Immuno-Oncology Technology, 7, 10.1016/j.iotech.2020.06.002 Treps, 2017, Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles, J. Extracell. Vesicles, 6, 10.1080/20013078.2017.1359479 Itatani, 2018, Resistance to anti-angiogenic therapy in Cancer—alterations to Anti-VEGF pathway, Int. J. Mol. Sci., 19, 10.3390/ijms19041232 Ko, 2019, Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake, Commun. Biol., 2, 10.1038/s42003-019-0609-x Zeng, 2019, Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis, J. Extracell. Vesicles, 8, 10.1080/20013078.2019.1629865 Nazarenko, 2010, Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation, Cancer Res., 70, 1668, 10.1158/0008-5472.CAN-09-2470 Svensson, 2011, Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2–mediated heparin-binding EGF signaling in endothelial cells, Proc. Natl. Acad. Sci. U.S.A., 108, 13147, 10.1073/pnas.1104261108 Klein, 2018, The tumor vascular endothelium as decision maker in Cancer therapy, Front. Oncol., 8, 10.3389/fonc.2018.00367 Yang, 2018, Exosome-derived miR-130a activates angiogenesis in gastric Cancer by targeting C-MYB in vascular endothelial cells, Mol. Ther., 26, 2466, 10.1016/j.ymthe.2018.07.023 Hsu, 2017, Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1, Oncogene, 36, 4929, 10.1038/onc.2017.105 Deng, 2020, Exosome miR-155 derived from gastric carcinoma promotes angiogenesis by targeting the c-MYB/VEGF Axis of endothelial cells, Mol. Ther. Nucleic Acids, 19, 1449, 10.1016/j.omtn.2020.01.024 Li, 2020, Hypoxic cancer-secreted exosomal miR-182-5p promotes glioblastoma angiogenesis by targeting kruppel-like factor 2 and 4, Mol. Cancer Res., 18, 1218, 10.1158/1541-7786.MCR-19-0725 Duan, 2019, Exosomal miR-17-5p promotes angiogenesis in nasopharyngeal carcinoma via targeting BAMBI, J. Cancer, 10, 6681, 10.7150/jca.30757 Tichet, 2015, Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis, Nat. Commun., 6, 10.1038/ncomms7993 Zeng, 2018, Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis, Nat. Commun., 9, 10.1038/s41467-018-07810-w Treps, 2015, Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma, Oncogene, 35, 2615, 10.1038/onc.2015.317 Fang, 2018, Hepatoma cell‐secreted exosomal microRNA‐103 increases vascular permeability and promotes metastasis by targeting junction proteins, Hepatology, 68, 1459, 10.1002/hep.29920 Lin, 2020, Exosomes derived from HeLa cells break down vascular integrity by triggering endoplasmic reticulum stress in endothelial cells, J. Extracell. Vesicles, 9, 10.1080/20013078.2020.1722385 Miyazawa, 2019, Regulation of endothelial cell permeability by platelet-derived extracellular vesicles, J. Trauma Acute Care Surg., 86, 931, 10.1097/TA.0000000000002230 Ma, 2019, Role of neutrophil extracellular traps and vesicles in regulating vascular endothelial permeability, Front. Immunol., 10, 10.3389/fimmu.2019.01037 Schlesinger, 2018, Role of platelets and platelet receptors in cancer metastasis, J. Hematol. Oncol., 11, 10.1186/s13045-018-0669-2 Wu, 2020, Neutrophils in the tumor microenvironment, Tumor Microenviron., 1 Osswald, 2015, Brain tumour cells interconnect to a functional and resistant network, Nature, 528, 93, 10.1038/nature16071 Magnon, 2013, Autonomic nerve development contributes to prostate cancer progression, Science, 341, 10.1126/science.1236361 Venkatesh, 2019, Electrical and synaptic integration of glioma into neural circuits, Nature, 573, 539, 10.1038/s41586-019-1563-y Venkataramani, 2019, Glutamatergic synaptic input to glioma cells drives brain tumour progression, Nature, 573, 532, 10.1038/s41586-019-1564-x Zeng, 2019, Synaptic proximity enables NMDAR signalling to promote brain metastasis, Nature, 573, 526, 10.1038/s41586-019-1576-6 Amit, 2020, Loss of p53 drives neuron reprogramming in head and neck cancer, Nature, 578, 449, 10.1038/s41586-020-1996-3 Lin, 2015, Carvedilol use is associated with reduced cancer risk: a nationwide population-based cohort study, Int. J. Cardiol., 184, 9, 10.1016/j.ijcard.2015.02.015 Napoli, 2020, Loss of p53 protein strikes a nerve to aid tumour growth, Nature, 578, 367, 10.1038/d41586-020-00328-6 Yu, 2018, Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype, Cancer Lett., 433, 210, 10.1016/j.canlet.2018.06.041 Hallal, 2018, Extracellular vesicles released by glioblastoma cells stimulate normal astrocytes to acquire a tumor-supportive phenotype via p53 and MYC signaling pathways, Mol. Neurobiol., 56, 4566, 10.1007/s12035-018-1385-1 Oushy, 2017, Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype, Philos. Trans. Biol. Sci., 373, 10.1098/rstb.2016.0477 Morad, 2019, Tumor-derived extracellular vesicles breach the intact blood–Brain barrier via Transcytosis, ACS Nano, 13, 13853, 10.1021/acsnano.9b04397 Tominaga, 2015, Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier, Nat. Commun., 6, 10.1038/ncomms7716 Wiklander, 2019, Advances in therapeutic applications of extracellular vesicles, Sci. Transl. Med., 11, 10.1126/scitranslmed.aav8521 Cossetti, 2014, Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells, Mol. Cell, 56, 193, 10.1016/j.molcel.2014.08.020 Berenguer, 2018, Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1446660 Bebelman, 2020, The convergence of extracellular vesicle and GPCR biology, Trends Pharmacol. Sci., 41, 627, 10.1016/j.tips.2020.07.001 Zhang, 2017, Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis, Nat. Commun., 8 Walker, 2018, Role of extracellular matrix in development and Cancer progression, Int. J. Mol. Sci., 19, 10.3390/ijms19103028 Benyon, 2001, Extracellular matrix degradation and the role of hepatic stellate cells, Semin. Liver Dis., 21, 373, 10.1055/s-2001-17552 Etoh, 2000, Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness, Gut, 47, 50, 10.1136/gut.47.1.50 Shan, 2018, Hypoxia-induced matrix Metalloproteinase-13 expression in exosomes from nasopharyngeal carcinoma enhances metastases, Cell Death Dis., 9, 10.1038/s41419-018-0425-0 Giusti, 2008, Cathepsin B mediates the pH-Dependent proinvasive activity of tumor-shed microvesicles, Neoplasia, 10, 481, 10.1593/neo.08178 Rilla, 2014, Hyaluronan-coated extracellular vesicles—a novel link between hyaluronan and Cancer, Hyaluronan signaling and turnover, Adv. Cancer Res., 121, 10.1016/B978-0-12-800092-2.00005-8 Härkönen, 2019, CD44s assembles hyaluronan coat on filopodia and extracellular vesicles and induces tumorigenicity of MKN74 gastric carcinoma cells, Cells, 8, 10.3390/cells8030276 Skandalis, 2019, Hyaluronan-CD44 axis orchestrates cancer stem cell functions, Cell. Signal., 63, 10.1016/j.cellsig.2019.109377 Hong, 2019, Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity, J. Extracell. Vesicles, 8, 10.1080/20013078.2019.1670893 Liu, 2019, Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance, Biomaterials, 223, 10.1016/j.biomaterials.2019.119475 Cerezo-Magaña, 2020, The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment, Semin. Cancer Biol., 62, 99, 10.1016/j.semcancer.2019.07.001 Bandari, 2018, Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior, Matrix Biol., 65, 104, 10.1016/j.matbio.2017.09.001 Johansson, 1997, Fibronectin-integrin interactions, Front. Biosci., 2, d126, 10.2741/A178 Chanda, 2019, Fibronectin on the surface of extracellular vesicles mediates fibroblast invasion, Am. J. Respir. Cell Mol. Biol., 60, 279, 10.1165/rcmb.2018-0062OC Sung, 2017, Exosome secretion promotes chemotaxis of cancer cells, Cell Adh. Migr., 11, 187, 10.1080/19336918.2016.1273307 Sung, 2015, Directional cell movement through tissues is controlled by exosome secretion, Nat. Commun., 6, 10.1038/ncomms8164 Hanahan, 2000, The hallmarks of Cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Hanahan, 2011, Hallmarks of Cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Shi, 2020, Metabolism in tumor microenvironment: implications for cancer immunotherapy, MedComm, 1, 47, 10.1002/mco2.6 Fong, 2015, Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis, Nat. Cell Biol., 17, 183, 10.1038/ncb3094 Skotland, 2020, An emerging focus on lipids in extracellular vesicles, Adv. Drug Deliv. Rev., 10.1016/j.addr.2020.03.002 Clement, 2020, Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells, EMBO J., 39, 10.15252/embj.2019102525 Sergentanis, 2013, Obesity and risk of malignant melanoma: a meta-analysis of cohort and case–control studies, Eur. J. Cancer, 49, 642, 10.1016/j.ejca.2012.08.028 Sansone, 2017, Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer, Proc. Natl. Acad. Sci. U.S.A., 114, E9066, 10.1073/pnas.1704862114 Yan, 2018, Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells, Nat. Cell Biol., 20, 597, 10.1038/s41556-018-0083-6 Leone, 2020, Metabolism of immune cells in cancer, Nat. Rev. Cancer, 20, 516, 10.1038/s41568-020-0273-y Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187 Husain, 2013, Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells, J. Immunol., 191, 1486, 10.4049/jimmunol.1202702 Clayton, 2011, Cancer exosomes express CD39 and CD73, which suppress t cells through Adenosine production, J. Immunol., 187, 676, 10.4049/jimmunol.1003884 Feitelson, 2015, Sustained proliferation in cancer: mechanisms and novel therapeutic targets, Semin. Cancer Biol., 35, S25, 10.1016/j.semcancer.2015.02.006 Fernald, 2013, Evading apoptosis in cancer, Trends Cell Biol., 23, 620, 10.1016/j.tcb.2013.07.006 Borzi, 2019, c-Myc shuttled by tumour-derived extracellular vesicles promotes lung bronchial cell proliferation through miR-19b and miR-92a, Cell Death Dis., 10, 10.1038/s41419-019-2003-5 Takasugi, 2017, Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2, Nat. Commun., 8, 10.1038/ncomms15728 Ozawa, 2018, Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells, Breast Cancer Res. Treat., 172, 713, 10.1007/s10549-018-4925-5 Cappellesso, 2014, Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions, Cancer Cytopathol., 122, 685, 10.1002/cncy.21442 Matsuhashi, 2019, Control mechanisms of the tumor suppressor PDCD4: expression and functions, Int. J. Mol. Sci., 20, 10.3390/ijms20092304 Mensà, 2020, Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells, J. Extracell. Vesicles, 9, 10.1080/20013078.2020.1725285 Yang, 2013, Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro, Mol. Med. Rep., 8, 1272, 10.3892/mmr.2013.1634 Gupta, 2006, Cancer metastasis: Building a framework, Cell, 127, 679, 10.1016/j.cell.2006.11.001 Jiang, 2015, Tissue invasion and metastasis: molecular, biological and clinical perspectives, Semin. Cancer Biol., 35, S244, 10.1016/j.semcancer.2015.03.008 Mo, 2021, Extracellular vesicle-associated organotropic metastasis, Cell Proliferation, 54, 10.1111/cpr.12948 Le, 2014, miR-200–containing extracellular vesicles promote breast cancer cell metastasis, J. Clin. Invest., 124, 5109, 10.1172/JCI75695 Zheng, 2020, Extracellular vesicle‐derived circ_SLC19A1 promotes prostate cancer cell growth and invasion through the miR‐497/septin 2 pathway, Cell Biol. Int., 44, 1037, 10.1002/cbin.11303 Campos, 2018, Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines, Nanomedicine, 13, 2597, 10.2217/nnm-2018-0094 Gonzalez-Avila, 2019, Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer, Crit. Rev. Oncol. Hematol., 137, 57, 10.1016/j.critrevonc.2019.02.010 Colangelo, 2020, Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: the role of CD147 (EMMPRIN) and ionizing radiation, Cell Commun. Signal., 18, 10.1186/s12964-019-0494-4 Liu, 2020, Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non–small cell lung cancer after concurrent chemoradiation, Sci. Adv., 6, 10.1126/sciadv.aaz6162 Rana, 2011, Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: impact on tumor cell motility, Int. J. Biochem. Cell Biol., 43, 106, 10.1016/j.biocel.2010.10.002 Whiteside, 2017, The role of tumor-derived exosomes in epithelial mesenchymal transition (EMT), Transl. Cancer Res., 6, S90, 10.21037/tcr.2017.02.13 Souza, 2018, Extracellular vesicles as drivers of epithelial-mesenchymal transition and carcinogenic characteristics in normal prostate cells, Mol. Carcinog., 57, 503, 10.1002/mc.22775 Negrini, 2010, Genomic instability — an evolving hallmark of cancer, Nat. Rev. Mol. Cell Biol., 11, 220, 10.1038/nrm2858 Malkin, 2020, Bioactive DNA from extracellular vesicles and particles, Cell Death Dis., 11, 10.1038/s41419-020-02803-4 Vagner, 2018, Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1505403 Fromont, 2013, 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy, Hum. Pathol., 44, 1617, 10.1016/j.humpath.2013.01.012 Chennakrishnaiah, 2020, Extracellular vesicles from genetically unstable, oncogene-driven cancer cells trigger micronuclei formation in endothelial cells, Sci. Rep., 10, 10.1038/s41598-020-65640-7 Tang, 2018, Active DNA end processing in micronuclei of ovarian cancer cells, BMC Cancer, 18, 10.1186/s12885-018-4347-0 Mo, 2018, Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4, Br. J. Cancer, 119, 492, 10.1038/s41416-018-0192-9 Sun, 2019, Future of radiotherapy in nasopharyngeal carcinoma, Br. J. Radiol., 92, 10.1259/bjr.20190209 Caudell, 2017, The future of personalised radiotherapy for head and neck cancer, Lancet Oncol., 18, e266, 10.1016/S1470-2045(17)30252-8 Surova, 2012, Various modes of cell death induced by DNA damage, Oncogene, 32, 3789, 10.1038/onc.2012.556 Huang, 2020, DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer, Signal Transduct. Target. Ther., 5, 10.1038/s41392-020-0150-x Liu, 2020, Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer, Int. J. Oral Sci., 12, 10.1038/s41368-020-00087-0 Zhang, 2019, LMP1‐positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling, Cancer Med., 8, 6082, 10.1002/cam4.2506 Roy, 2018, The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response, Mutat. Res. Toxicol. Environ. Mutagen., 836, 89, 10.1016/j.mrgentox.2018.05.018 Boelens, 2014, Petra J. Ter Brugge, J. Jonkers, J. Slingerland, Andy J. Minn, exosome transfer from stromal to breast Cancer cells regulates therapy resistance pathways, Cell, 159, 499, 10.1016/j.cell.2014.09.051 Tang, 2016, Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells, J. Exp. Clin. Cancer Res., 35 Zhao, 2019, Expression profiles and potential functions of circular RNAs in extracellular vesicles isolated from radioresistant glioma cells, Oncol. Rep., 10.3892/or.2019.6972 Dai, 2018, AHIF promotes glioblastoma progression and radioresistance via exosomes, Int. J. Oncol., 10.3892/ijo.2018.4621 Sugerman, 2013, Chemotherapy, Jama, 310, 10.1001/jama.2013.5525 Assaraf, 2019, The multi-factorial nature of clinical multidrug resistance in cancer, Drug Resist. Updates, 46, 10.1016/j.drup.2019.100645 Seth, 2019, Pre-existing functional heterogeneity of tumorigenic compartment as the origin of Chemoresistance in pancreatic tumors, Cell Rep., 26, 10.1016/j.celrep.2019.01.048 Levchenko, 2005, Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells, Proc. Natl. Acad. Sci. U.S.A., 102, 1933, 10.1073/pnas.0401851102 Wang, 2019, Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance, Mol. Cancer, 18, 10.1186/s12943-019-1114-z Bebawy, 2009, Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells, Leukemia, 23, 1643, 10.1038/leu.2009.76 Zhang, 2014, Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance, Eur. J. Pharmacol., 738, 83, 10.1016/j.ejphar.2014.05.026 Kyprianou, 2012, Docetaxel-resistance in prostate Cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes, PLoS One, 7 Ning, 2017, UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer, J. Surg. Oncol., 115, 932, 10.1002/jso.24614 Joly, 2011, Structure and function of ABCG2-Rich extracellular vesicles mediating multidrug resistance, PLoS One, 6 Ifergan, 2005, Novel extracellular vesicles mediate an ABCG2-Dependent anticancer drug sequestration and resistance, Cancer Res., 65, 10952, 10.1158/0008-5472.CAN-05-2021 Xie, 2020, Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance, Signal Transduct. Target. Ther., 5, 10.1038/s41392-020-0151-9 Zhang, 2019, A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer, EBioMedicine, 44, 311, 10.1016/j.ebiom.2019.05.003 Zhang, 2019, c‑Myc maintains the self‑renewal and chemoresistance properties of colon cancer stem cells, Oncol. Lett. Sun, 2020, The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer, Theranostics, 10, 1981, 10.7150/thno.37621 Kreger, 2016, The enrichment of survivin in exosomes from breast Cancer cells treated with paclitaxel promotes cell survival and chemoresistance, Cancers, 8, 10.3390/cancers8120111 Lucotti, 2013, Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival, Mol. Cancer, 12, 10.1186/1476-4598-12-52 Kaplan, 2016, Testosterone therapy in men with prostate Cancer, Eur. Urol., 69, 894, 10.1016/j.eururo.2015.12.005 Carmocan, 2017, Hormone therapy in breast Cancer, Chirurgia, 112 Augimeri, 2020, Evidence for enhanced exosome production in aromatase inhibitor-resistant breast Cancer cells, Int. J. Mol. Sci., 21, 10.3390/ijms21165841 Semina, 2018, Exosome-mediated transfer of Cancer cell resistance to antiestrogen drugs, Molecules, 23, 10.3390/molecules23040829 Rontogianni, 2019, Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping, Commun. Biol., 2, 10.1038/s42003-019-0570-8 Del Re, 2017, The detection of androgen receptor splice variant 7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate Cancer patients, Eur. Urol., 71, 680, 10.1016/j.eururo.2016.08.012 Jiao, 2018, Advances in studies of tyrosine kinase inhibitors and their acquired resistance, Mol. Cancer, 17, 10.1186/s12943-018-0801-5 Lee, 2018, Molecular targeted therapy: treating cancer with specificity, Eur. J. Pharmacol., 834, 188, 10.1016/j.ejphar.2018.07.034 Ke, 2017, Molecular targeted therapy of cancer: the progress and future prospect, Front. Lab. Med., 1, 69, 10.1016/j.flm.2017.06.001 Lindeman, 2013, J. Thorac. Oncol., 8, 823, 10.1097/JTO.0b013e318290868f Cheng, 2017, Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine, Mod. Pathol., 31, 24, 10.1038/modpathol.2017.104 Hughes, 2006, Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results, Blood, 108, 28, 10.1182/blood-2006-01-0092 Messersmith, 2008, Targeting EGFR in colorectal Cancer, N. Engl. J. Med., 359, 1834, 10.1056/NEJMe0806778 Ferrara, 2005, Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy, Biochem. Biophys. Res. Commun., 333, 328, 10.1016/j.bbrc.2005.05.132 Ortega, 2019, EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform, Talanta, 194, 243, 10.1016/j.talanta.2018.10.016 Castellanos-Rizaldos, 2018, Exosome-based detection ofEGFRT790M in plasma from non–Small cell lung Cancer patients, Clin. Cancer Res., 24, 2944, 10.1158/1078-0432.CCR-17-3369 Read, 2017, Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles, Eur. J. Cancer, 70, 62, 10.1016/j.ejca.2016.10.017 Choi, 2014, Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment, Proteomics, 14, 1845, 10.1002/pmic.201400008 Fang, 2020, PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy, Transl. Lung Cancer Res., 9, 1258, 10.21037/tlcr-20-141 Jing, 2018, Exosome‑mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR‑21, Oncol. Lett. Lei, 2018, Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer, Oncol. Rep., 10.3892/or.2018.6762 Zhong, 2019, LncRNA H19 regulates PI3K–akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network, Cancer Cell Int., 19, 10.1186/s12935-019-0866-2 Zhang, 2018, Exosome-mediated transfer of lncRNA RP11‑838N2.4 promotes erlotinib resistance in non-small cell lung cancer, Int. J. Oncol., 10.3892/ijo.2018.4412 Chen, 2020, lncRNA RP11-838N2.3 promoted cisplatin resistance in lung adenocarcinoma, Biomed Res. Int., 2020, 1 Takenaka, 2019, Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells, Int. J. Pharm., 572, 10.1016/j.ijpharm.2019.118762 Kwok, 2019, Transfer of extracellular Vesicle-Associated-RNAs induces drug resistance in ALK-Translocated lung adenocarcinoma, Cancers, 11, 10.3390/cancers11010104 Cesi, 2018, A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells, Mol. Cancer, 17, 10.1186/s12943-018-0886-x Vella, 2017, Intercellular resistance to BRAF inhibition can Be mediated by extracellular vesicle–Associated PDGFRβ, Neoplasia, 19, 932, 10.1016/j.neo.2017.07.002 Kasumova, 2018, Abstract A35: BRAF inhibition increases exosomal PD-L1 protein expression in melanoma, Checkpoints Immunomodul., A35 Kim, 2019, Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer, Exp. Mol. Med., 51, 1 Bollag, 2010, Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma, Nature, 467, 596, 10.1038/nature09454 Gad, 2019, Targeting CDC7 sensitizes resistance melanoma cells to BRAFV600E-specific inhibitor by blocking the CDC7/MCM2-7 pathway, Sci. Rep., 9, 10.1038/s41598-019-50732-w Jurj, 2020, Basic knowledge on BCR-ABL1-positive extracellular vesicles, Biomark. Med., 10.2217/bmm-2019-0510 Min, 2018, Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365, Exp. Cell Res., 362, 386, 10.1016/j.yexcr.2017.12.001 Peng, 2012, Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells, Chin. J. Cancer, 31, 110, 10.5732/cjc.011.10327 Kolba, 2019, Tunneling nanotube-mediated intercellular vesicle and protein transfer in the stroma-provided imatinib resistance in chronic myeloid leukemia cells, Cell Death Dis., 10, 10.1038/s41419-019-2045-8 Abbott, 2012, Dasatinib: from treatment of imatinib-resistant or -Intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemia, Clin. Ther., 34, 272, 10.1016/j.clinthera.2012.01.009 Liu, 2016, Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells, Int. J. Mol. Sci., 17, 10.3390/ijms17040531 Li, 2020, Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner, Cancer Lett., 492, 71, 10.1016/j.canlet.2020.08.030 Simon, 2018, Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma, Mol. Cancer, 17, 10.1186/s12943-018-0878-x Kruger, 2019, Advances in cancer immunotherapy 2019 – latest trends, J. Exp. Clin. Cancer Res., 38, 10.1186/s13046-019-1266-0 Finn, 2008, Cancer immunology, N. Engl. J. Med., 358, 2704, 10.1056/NEJMra072739 Darvin, 2018, Immune checkpoint inhibitors: recent progress and potential biomarkers, Exp. Mol. Med., 50, 1, 10.1038/s12276-018-0191-1 Liu, 2018, Mechanisms of resistance to immune checkpoint blockade, Am. J. Clin. Dermatol., 20, 41, 10.1007/s40257-018-0389-y Chen, 2018, Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response, Nature, 560, 382, 10.1038/s41586-018-0392-8 Bhat, 2017, Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity, Cell Death Dis., 8, e2836, 10.1038/cddis.2017.67 Garcia-Diaz, 2017, Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression, Cell Rep., 19, 1189, 10.1016/j.celrep.2017.04.031 Theodoraki, 2018, Clinical significance of PD-L1+Exosomes in plasma of head and neck Cancer patients, Clin. Cancer Res., 24, 896, 10.1158/1078-0432.CCR-17-2664 Del Re, 2018, PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC, Br. J. Cancer, 118, 820, 10.1038/bjc.2018.9 Vari, 2018, Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL, Blood, 131, 1809, 10.1182/blood-2017-07-796342 Nagano, 2018, PD-L1 expression on circulating monocytes in patients with breast cancer, Ann. Oncol., 29, 10.1093/annonc/mdy427.008 Haderk, 2017, Tumor-derived exosomes modulate PD-L1 expression in monocytes, Sci. Immunol., 2, 10.1126/sciimmunol.aah5509 Yang, 2018, Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth, Cell Res., 28, 862, 10.1038/s41422-018-0060-4 Poggio, 2019, Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory, Cell, 177, 10.1016/j.cell.2019.02.016 Chatterjee, 2020, Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer, Carcinogenesis Gong, 2019, Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer, J. Exp. Med., 216, 982, 10.1084/jem.20180870 Orme, 2020, ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance, OncoImmunology, 9, 10.1080/2162402X.2020.1744980 Orme, 2020, Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles, J. Immunother. Cancer, 8, 10.1136/jitc-2020-001113 Zhang, 2020, Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma, Mol. Cancer, 19, 10.1186/s12943-020-01222-5